Statement on today´s publication of the World Health Organisation (WHO) Report on e-cigarettes
Gerry Stimson* | 26 August 2014
New estimates double size of US e-cigarette market; increasing importance of refillable and modified devices.
Gerry Stimson 29 | March 2014
The fast moving world of e-cigarettes means that it is hard to track the dynamics of this changing scene. There is a lack of good information on the size of the vaping population, trends in the sales of e-cigarettes, and what devices vapers are using. Academic and survey research on the size and characteristics of the vaping population is still minimal, and a picture of what is happening needs to be pieced together from various sources of information including sales and market data.
UK Public Health Doctors and e-cigarettes – why this matters
Gerry Stimson and Paddy Costall | 19 January 2014
We struggle to understand why so many public health colleagues are anti-pathetic to electronic cigarettes. The uptake of e-cigarettes has been a consumer-led public health revolution. At no cost to the NHS, and without government or public health support and promotion, thousands of people have found that e-cigarettes help them switch from smoking. Using e-cigarettes is a classic harm reduction approach – a safer product and delivery device for those who do not want to give up nicotine. It fits two public health principles – the first is to reduce harms to populations and the second is to engage and work with populations in their endeavour to lead healthier lives.
European Tobacco Products Directive – Last minute attempt by the European Commission to introduce medicines regulation in all but name
Gerry Stimson | 25 November 2013
The European Parliament voted on October 8th voted to reject medicines regulation for e-cigarettes. Instead it passed Amendment 170 which sought to regulate e-cigarettes as consumer products. The main elements of this amendment were that medicines legislation would apply to products where a health claim is made i.e. that the product can be used for treating or preventing disease.
European Parliament votes against proposal to regulate e-cigarettes as medicines
Gerry Stimson | 13 October 2013
As the Telegraph put it, ‘The decision by MEPs to reject a European Commission proposal to treat electronic cigarettes as medicinal products was as sensible as it was unexpected’.
Public health call for European ban on snus to be lifted
Gerry Stimson | 29 September 2013
What were they thinking of at the European Commission when they proposed continuing with the ban on snus? The ban, and the proposal to control e-cigarettes as medicines, ranks as public health folly of the highest order.
Costs and burdens of medicines regulation for e-cigarettes
Gerry Stimson | 21 September 2013
New report by Clive Bates and Gerry Stimson on the Costs and burdens of medicines regulation for e-cigarettes.
What were the MHRA, the Department of Health, and their health advisers thinking when they embarked on the e-cigarettes as medicines route? The more you analyse it, the more medicines regulation appears to lead to a monstrous perversion of public health objectives.
Letter to MEPs on the EU Parliament ENVI Committee
Gerry Stimson | 23 May 2013
In a letter to MEPs on the EU Parliament ENVI Committee, regarding the proposed regulation of electronic cigarettes in the draft Tobacco Products Directive, Professor Gerry Stimson makes the case for ‘twin-track’ regulation
April 22, 2013
I am writing to you concerning the draft Tobacco Products Directive and in particular Article 18 which seeks to regulate nicotine containing products (NCP) - including electronic cigarettes - as medicinal products.